Cassady Schiller Wealth Management, LLC Viking Therapeutics, Inc. Transaction History
Cassady Schiller Wealth Management, LLC
- $259 Million
- Q3 2024
A detailed history of Cassady Schiller Wealth Management, LLC transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Cassady Schiller Wealth Management, LLC holds 50 shares of VKTX stock, worth $3,293. This represents 0.0% of its overall portfolio holdings.
Number of Shares
50
Previous 50
-0.0%
Holding current value
$3,293
Previous $2,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding VKTX
# of Institutions
478Shares Held
66.1MCall Options Held
6.24MPut Options Held
3.01M-
Vanguard Group Inc Valley Forge, PA10.1MShares$665 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$397 Million0.01% of portfolio
-
State Street Corp Boston, MA5.12MShares$337 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.25MShares$148 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA1.86MShares$122 Million0.01% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $5.05B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...